Labetalol Hydrochloride
NDC 68001-382, Labetalol Hydrochloride, tablet, film coated, from BluePoint Laboratories Inc..
- Product NDC
- 68001-382
- Status
- Listed
- Labeler
- BluePoint Laboratories Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207743
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68001-382 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LABETALOL HYDROCHLORIDE200 mg/1
Pharmacologic classes
Adrenergic beta-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68001-382-00 | 68001038200 | 100 TABLET, FILM COATED in 1 BOTTLE (68001-382-00) |
| 68001-382-03 | 68001038203 | 500 TABLET, FILM COATED in 1 BOTTLE (68001-382-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/63ede355-42ec-4c52-a941-51e5f6b35ed6NADAC price for package 68001038200
GET /v1/drugs/nadac/68001038200NADAC price for package 68001038203
GET /v1/drugs/nadac/68001038203
Use it
Look up 68001-382 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68001-382 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68001-382. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.